VACCINE AND TREATMENT EVALUATION UNITS (VTEU): PROTOCOL DEVELOPMENT AND IMPLEMENTATION, FOR A PHASE 1 ANTHRAX VACCINE TRIAL

疫苗和治疗评估单位 (VTEU)：第一阶段炭疽疫苗试验的方案制定和实施

• 批准号: 10209926
• 负责人: KAREN KOTLOFF
• 金额: $ 95.24万
• 依托单位: UNIVERSITY OF MARYLAND BALTIMORE
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-06-05 至 2022-07-01
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10209926
• 关键词: Anthrax Vaccines; Bacillus anthracis; Communicable Diseases; Conduct Clinical Trials; Contracts; Evaluation; Individual; Phase; Population; Resources; Vaccines; combat; design; named group; phase I trial; programs; protocol development; vaccine trial

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

该计划由学术中心和组织内的个人合同联盟组成，为临床试验的设计和实施提供现成的资源，以评估有前景的抗击传染病的产品。一般来说，产品会在正常健康人群中进行评估；然而，也可以接触特殊人群。